Cargando…
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of currently available anticancer therapies. Recent studies have shown that epigenetic reprogramming regulates the expression of characteristic marker proteins and tumor plasticity associated with cancer cell survival...
Autores principales: | Jin, Ming Li, Jeong, Kwang Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394043/ https://www.ncbi.nlm.nih.gov/pubmed/37394580 http://dx.doi.org/10.1038/s12276-023-01014-z |
Ejemplares similares
-
Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
por: Sim, Wynne, et al.
Publicado: (2022) -
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
por: Yang, Liu, et al.
Publicado: (2021) -
Immune evasion by cancer stem cells
por: Tsuchiya, Hiroyuki, et al.
Publicado: (2021) -
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022) -
Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
por: Parcesepe, Pietro, et al.
Publicado: (2016)